Trials / Completed
CompletedNCT00210444
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect on healing rates of two different prognostic factors in patients treated with Dysport® for anal fissure: duration of fissure and dose of study drug
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A |
Timeline
- Start date
- 2003-06-01
- Completion
- 2006-12-01
- First posted
- 2005-09-21
- Last updated
- 2020-04-29
Locations
7 sites across 4 countries: Czechia, Poland, Romania, Tunisia
Source: ClinicalTrials.gov record NCT00210444. Inclusion in this directory is not an endorsement.